ERN Skin webinar on the EBStatMax project outcomes given by Prof. Johan Bauer and Dr. Georg Zimmermann on 30/01/2024
Bookmark this resourceClinical Trial Design
Advisory Committee for Therapeutics (ACT) toolkit – Agenda Template
Published by UNEW
AdviceClinical DevelopmentClinical Trial DesignPreclinical ResearchResearch and Drug DevelopmentTranslational ResearchTREAT-NMDThis agenda template can be used in conjunction with the ACT toolkit. For further information, please see the ACT toolkit.
Bookmark this resource
Advisory Committee for Therapeutics (ACT) toolkit – Applicant agreement template
Published by UNEW
AdviceClinical DevelopmentClinical Trial DesignPreclinical ResearchResearch and Drug DevelopmentTranslational ResearchTREAT-NMDThis applicant agreement template can be used in conjunction with the ACT toolkit. For further information, please see the ACT toolkit.
Bookmark this resource
Advisory Committee for Therapeutics (ACT) toolkit – Conflict of interest (CoI) form template
Published by UNEW
AdviceClinical DevelopmentClinical Trial DesignPreclinical ResearchResearch and Drug DevelopmentTranslational ResearchTREAT-NMDThis conflict of interest form template can be used in conjunction with the ACT toolkit. For further information, please see the ACT toolkit.
Bookmark this resource
Advisory Committee for Therapeutics (ACT) toolkit – Pre-application form template
Published by UNEW
AdviceClinical DevelopmentClinical Trial DesignPreclinical ResearchResearch and Drug DevelopmentTranslational ResearchTREAT-NMDThis pre-application form template can be used in conjunction with the ACT toolkit. For further information, please see the ACT toolkit.
Bookmark this resource
Advisory Committee for Therapeutics (ACT) toolkit – Report to applicant template
Published by UNEW
AdviceClinical DevelopmentClinical Trial DesignPreclinical ResearchResearch and Drug DevelopmentTranslational ResearchTREAT-NMDThis report to the applicant template can be used in conjunction with the ACT toolkit. For further information, please see the ACT toolkit.
Bookmark this resource
EBStatMax Project Overview
Published by EBStatMax team
Clinical Trial DesignResearch and Drug DevelopmentThis document provides a project overview and a summary. It can be used as the body of the innovation management toolbox website
Bookmark this resource
A neutral comparison of statistical methods for analyzing longitudinally measured ordinal outcomes in rare diseases
Published by Wiley
Clinical Trial DesignResearch and Drug DevelopmentPeer reviewed journal article on a neutral comparison of statistical methods for longitudinal ordinal outcomes
View this resource Bookmark this resource
How to Analyze Continuous and Discrete Repeated Measures in Small-Sample Cross-Over Trials?
Published by Oxford Academic
Clinical Trial DesignResearch and Drug DevelopmentPeer reviewed journal article on a neutral comparison of statistical methods for longitudinal count data and binary data
View this resource Bookmark this resource
Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials
Published by Springer
Clinical Trial DesignResearch and Drug DevelopmentPeer reviewed journal article on statistical recommendations for longitudinal cross-over studies in rare disease research
View this resource Bookmark this resource